Nathan Rice
Stock Analyst at Piper Sandler
(1.16)
# 1824
Out of 5,331 analysts
59
Total ratings
45.16%
Success rate
11.74%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BFC Bank First | Maintains: Neutral | 110 111 | 113.22 | -1.96% | 6 | Apr 17, 2025 | |
MBIN Merchants Bancorp | Maintains: Overweight | 53 57 | 31.34 | 80.28% | 7 | Jan 30, 2025 | |
FMBH First Mid Bancshares | Maintains: Overweight | 46 47 | 35.93 | 30.81% | 3 | Nov 1, 2024 | |
BY Byline Bancorp | Reiterates: Overweight | 34 34 | 26.45 | 28.54% | 8 | Oct 29, 2024 | |
CVS CVS Health | Maintains: Buy | 85 74 | 67.44 | 9.73% | 2 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 84 | 121.04 | -30.6% | 1 | Jan 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 197 | 179.79 | 9.57% | 8 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 11 9 | 9.75 | -7.69% | 1 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 40 | n/a | n/a | 1 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 530 435 | 471.81 | -7.8% | 4 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 233 | 334.08 | -30.26% | 3 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 83 | 60.05 | 38.22% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 15 | 16.3 | -7.98% | 1 | Dec 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 49 54 | n/a | n/a | 4 | Feb 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 31 | n/a | n/a | 2 | Jul 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Jul 24, 2017 |